UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029276
Receipt number R000033444
Scientific Title Activity of brown adipose tissue and characteristics of physical function in humans
Date of disclosure of the study information 2017/12/01
Last modified on 2018/03/29 21:40:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Activity of brown adipose tissue and characteristics of physical function in humans

Acronym

Activity of brown adipose tissue and characteristics of physical function in humans

Scientific Title

Activity of brown adipose tissue and characteristics of physical function in humans

Scientific Title:Acronym

Activity of brown adipose tissue and characteristics of physical function in humans

Region

Japan


Condition

Condition

obesity or type 2 diabetes

Classification by specialty

Endocrinology and Metabolism Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We hypothesized that the hepatokine selenoprotein P regulates the heat production in brown adipocytes. In fact, we found that hypothermia-resistance in selenoprotein P knockout mice and impairment in noradrenaline-induced heat production in primary brown adipocytes treated with selenoprotein P. In the current study, we measure blood levels of selenoprotein P in human subjects whose brown adipose tissue activity was measured by FDG-PET.

Basic objectives2

Others

Basic objectives -Others

Many researchers pay attention to decreased brown adipose tissue activity in people with obesity or type 2 diabetes. However, its mechanism is not fully understood.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The relationship between blood concentrations of hepatokine selenoprotein P and activity of brown adipose tissue measured by PET.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adult

Key exclusion criteria

Cases who are judged as inadequate for the subjects in the current study by the corresponding doctors of the current study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hirofumi Misu

Organization

Kanazawa University Graduate School of Medical Sciences

Division name

Department of Endocrinology and Metabolism

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa,Japan

TEL

+81-76-265-2712

Email

hmisu@m-kanazawa.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hirofumi Misu

Organization

Kanazawa University Graduate School of Medical Sciences

Division name

Department of Endocrinology and Metabolism

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa,Japan

TEL

+81-76-265-2712

Homepage URL


Email

hmisu@m-kanazawa.jp


Sponsor or person

Institute

Kanazawa University Graduate School of Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 09 Month 25 Day

Date of IRB


Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We compare selenoprotein P concentrations with brown adipose activity in one group without intervention.


Management information

Registered date

2017 Year 09 Month 25 Day

Last modified on

2018 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033444


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name